Outcome following intracranial hemorrhage associated with novel oral anticoagulants

Journal of Clinical Neuroscience

Volumn 22, Issue 1, 2015, Pages 212-215

  Kasliwal, Manish K ^a   Panos, Nicholas G ^a   Munoz, Lorenzo F ^a   Moftakhar, Roham ^a   Lopes, Demetrius K ^a   Byrne, Richard W ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apixaban; Dabigatran; Intracranial hemorrhages; Rivaroxaban; Treatment outcome

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ANTICOAGULANT AGENT; DABIGATRAN; RIVAROXABAN; ANTIDOTE; APIXABAN; PYRAZOLE DERIVATIVE; PYRIDONE DERIVATIVE;

AGED; ARTICLE; BRAIN HEMORRHAGE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; HEMOSTASIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RISK BENEFIT ANALYSIS; SUBDURAL HEMATOMA; THERAPY DELAY; TRACHEOSTOMY; TREATMENT OUTCOME; VERY ELDERLY; WEAKNESS; BLOOD CLOTTING TEST; CHEMICALLY INDUCED; INTRACRANIAL HEMORRHAGES; NEUROLOGIC EXAMINATION;

AGED, 80 AND OVER; ANTICOAGULANTS; ANTIDOTES; BLOOD COAGULATION TESTS; DABIGATRAN; HUMANS; INTERNATIONAL NORMALIZED RATIO; INTRACRANIAL HEMORRHAGES; MALE; NEUROLOGIC EXAMINATION; PYRAZOLES; PYRIDONES; RIVAROXABAN; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84920741721     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2014.04.025     Document Type: Article

References (25)

1. J.J. Flibotte, N. Hagan, and J. O'Donnell Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage Neurology 63 2004 1059 1064
2. S. Schulman, and M.A. Crowther How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch Blood 119 2012 3016 3023
3. P.R. Sinnaeve, M. Brueckmann, and A. Clemens Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation J Intern Med 271 2012 15 24
4. S.J. Connolly, M.D. Ezekowitz, and S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
5. C.B. Granger, J.H. Alexander, and J.J. McMurray Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
6. M.R. Patel, K.W. Mahaffey, and J. Garg Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
7. P. Teddy, and G. Nair Anti-stroke prophylaxis-The ethics of collateral damage J Clin Neurosci 19 2012 792 794
8. J.J. Provencio, I.R. Da Silva, and E.M. Manno Intracerebral hemorrhage: new challenges and steps forward Neurosurg Clin N Am 24 2013 349 359
9. D. Dowlatshahi, K.S. Butcher, and N. Asdaghi Poor prognosis in warfarin-Associated intracranial hemorrhage despite anticoagulation reversal Stroke 43 2012 1812 1817
10. A.J. Awad, B.P. Walcott, and C.J. Stapleton Dabigatran, intracranial hemorrhage, and the neurosurgeon Neurosurg Focus 34 2013 E7
11. D.N. Chang, W.E. Dager, and A.I. Chin Removal of dabigatran by hemodialysis Am J Kidney Dis 61 2013 487 489
12. B.C. Chen, A.D. Viny, and F.M. Garlich Hemorrhagic complications associated with dabigatran use Clin Toxicol (Phila) 50 2012 854 857
13. W.E. Dager, R.C. Gosselin, and A.J. Roberts Reversing dabigatran in life-threatening bleeding occurring during cardiac ablation with factor eight inhibitor bypassing activity Crit Care Med 41 2013 e42 e46
14. E.S. Eerenberg, P.W. Kamphuisen, and M.K. Sijpkens Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects Circulation 124 2011 1573 1579
15. A.C. Faust, and E.J. Peterson Management of dabigatran-Associated intracerebral and intraventricular hemorrhage: a Case Report J Emerg Med 46 2014 525 529
16. S.T. Garber, W. Sivakumar, and R.H. Schmidt Neurosurgical complications of direct thrombin inhibitors-catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran J Neurosurg 116 2012 1093 1096
17. R. Marlu, E. Hodaj, and A. Paris Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers Thromb Haemost 108 2012 217 224
18. G. Pernod, P. Albaladejo, and A. Godier Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013 Arch Cardiovasc Dis 106 2013 382 393
19. B. Ross, M.A. Miller, and K. Ditch Clinical experience of life-threatening dabigatran-related bleeding at a large, tertiary care, academic medical center: a case series J Med Toxicol 10 2014 223 228
20. C.Z. Simonsen, T. Steiner, and A. Tietze Dabigatran-related intracerebral hemorrhage resulting in hematoma expansion J Stroke Cerebrovasc Dis 23 2014 133 134
21. S.N. Wassef, T.J. Abel, and A. Grossbach Traumatic intracranial hemorrhage in patients taking dabigatran: report of 3 cases and review of the literature Neurosurgery 73 2013 E368 E373 [discussion E373-4]
22. M.A. Miyares, and K. Davis Newer oral anticoagulants: a review of laboratory monitoring options and reversal agents in the hemorrhagic patient Am J Health Syst Pharm 69 2012 1473 1484
23. M.K. Mittal, and A.A. Rabinstein Anticoagulation-related intracranial hemorrhages Curr Atheroscler Rep 14 2012 351 359
24. J. van Ryn, J. Stangier, and S. Haertter Dabigatran etexilate-A novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity Thromb Haemost 103 2010 1116 1127
25. T. Steiner, M. Böhm, and M. Dichgans Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban Clin Res Cardiol 102 2013 399 412